Evidence map›Paper›PMID 41097722›Full record

ReviewCancers2025

The Washout of Hepatocellular Carcinoma at Portal Venous Phase vs. Equilibrium Phase: Radiological and Clinicopathological Implication.

Kengo Yoshimitsu, Akihiro Nishie, Yukihisa Takayama, Shinji Tanaka, Keisuke Sato, Kousei Ishigami

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Temporal Differentiation of Nonperipheral Washout Refines Prognostic Stratification in HCC.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kengo YoshimitsuDepartment of Radiology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Akihiro NishieDepartment of Radiology, Graduate School of Medical Science, University of the Ryukyus, Okinawa 903-0215, Japan.
Yukihisa TakayamaDepartment of Radiology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.ORCID 0000-0002-2029-9316
Shinji TanakaDepartment of Radiology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Keisuke SatoDepartment of Radiology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Kousei IshigamiDepartment of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0001-8107-5570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal venous or late (equilibrium) phase washout is one of the well-known major imaging features of hepatocellular carcinoma (HCC). However, these two washouts stand for distinct intratumoral pathophysiological states and should be considered separately. Positive portal venous phase (PVP) washout has been shown to be related to high grade HCC, poor post operative survival rate, and positive PD-L1 or VETC. In contrast, there is indirect evidence that negative washout at equilibrium or late phase (EqP) may be related to biliary/stem cell subtype, which is biologically aggressive, and associated with an immune hot tumor microenvironment. Thus, although these two washouts represent different intratumoral pathophysiological conditions, both are closely related to biological aggressiveness or tumor microenvironment, which may be associated with the response to systemic therapies or post-surgical survival. In contemporary practice, gadoxetate-enhanced MRI restricts washout assessment in the PVP, whereas extracellular agent CT permits assessment in both the PVP and EqP; accordingly, this review addresses PVP washout on CT or extracellular agent MRI, PVP washout on gadoxetate-enhanced MRI, and EqP washout on CT. When washout information is integrated with other clinico-radiological features, more precise prediction of patient survival or response to systemic therapies would become possible in the future.

Indexed as

clinico-pathological implicationequilibrium phasehepatocellular carcinomaportal venous phasewashout

Identifiers

PMID41097722
PMCPMC12523583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.